國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Hemostasis." ]

切換: 標籤 | MARC模式 | ISBD

Thrombosis and hemostasis in cancer

Soff, Gerald.

Thrombosis and hemostasis in cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Thrombosis and hemostasis in canceredited by Gerald Soff.
其他作者:	Soff, Gerald.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xiv, 203 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Hemorrhagic diseases.
電子資源:	https://doi.org/10.1007/978-3-030-20315-3
ISBN:	9783030203153$q(electronic bk.)

Thrombosis and hemostasis in cancer
Thrombosis and hemostasis in cancer[electronic resource] /edited by Gerald Soff. - Cham :Springer International Publishing :2019. - xiv, 203 p. :ill., digital ;24 cm. - Cancer treatment and research,v.1790927-3042 ;. - Cancer treatment and research ;v. 114..

Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview -- Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients -- Pathophysiology 3. The role of platelets in cancer biology -- The risk of thrombosis in cancer. Clinical factors & possible role of primary prophylaxis -- Biomarkers of cancer-associated thromboembolism -- Thrombotic Risk from Chemotherapy and Other Cancer Therapies -- Treatment of VTE In Cancer. Historical Perspective and evolving role of the DOACs -- Etiology and Management of Upper Extremity, Central line associated thrombosis -- Management of Thrombocytopenia In Cancer Patients -- Microangiopathy in Cancer. Causes, Consequences, and Management -- Thrombosis in the Philadelphia chromosome-negative Myeloproliferative Neoplasms -- Anticoagulation in the setting of primary and metastatic brain tumors -- Hemorrhage in the cancer patient. APML and other specific high risk situations.

In this book, leaders in the field explore our current understanding of thrombosis and hemostasis in cancer and address key questions on the subject. Among the topics discussed are the mechanisms that cancers use to activate the coagulation system, and those by means of which an activated coagulation system can lead to more aggressive cancer growth. Clinical chapters examine the role of thrombosis prophylaxis and treatment, central line-associated thrombosis, and cancer-associated hemorrhage. Subsequent chapters deal with the management of chemotherapy-induced thrombocytopenia, anticoagulation in the presence of brain metastases, and other unique challenges in the interaction of thrombosis and hemostasis in cancer. It has been 150 years since Armand Trousseau first described the well-known association between cancer and an increased risk of thrombosis, which may be considered the first paraneoplastic syndrome ever identified. More recently, numerous studies have indicated that activation of the coagulation system by cancer not only increases the likelihood of thrombosis, but is also associated with a more aggressive cancer phenotype. By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists and clinicians alike.

ISBN: 9783030203153$q(electronic bk.)

Standard No.: 10.1007/978-3-030-20315-3doiSubjects--Topical Terms:

849773
Hemorrhagic diseases.

LC Class. No.: RC633 / .T476 2019

Dewey Class. No.: 616.15

Thrombosis and hemostasis in cancer
LDR:03253nmm a2200337 a 4500 001 563989
003 DE-He213
005 20191213094807.0
006 m d
007 cr nn 008maaau
008 200311s2019 gw s 0 eng d
020 $a 9783030203153$q(electronic bk.)
020 $a 9783030203146$q(paper)
024 7 $a 10.1007/978-3-030-20315-3 $2 doi
035 $a 978-3-030-20315-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC633 $b .T476 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.15 $2 23
090 $a RC633 $b .T531 2019
245 0 0 $a Thrombosis and hemostasis in cancer $h [electronic resource] / $c edited by Gerald Soff.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiv, 203 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer treatment and research, $x 0927-3042 ; $v v.179
505 0 $a Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview -- Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients -- Pathophysiology 3. The role of platelets in cancer biology -- The risk of thrombosis in cancer. Clinical factors & possible role of primary prophylaxis -- Biomarkers of cancer-associated thromboembolism -- Thrombotic Risk from Chemotherapy and Other Cancer Therapies -- Treatment of VTE In Cancer. Historical Perspective and evolving role of the DOACs -- Etiology and Management of Upper Extremity, Central line associated thrombosis -- Management of Thrombocytopenia In Cancer Patients -- Microangiopathy in Cancer. Causes, Consequences, and Management -- Thrombosis in the Philadelphia chromosome-negative Myeloproliferative Neoplasms -- Anticoagulation in the setting of primary and metastatic brain tumors -- Hemorrhage in the cancer patient. APML and other specific high risk situations.
520 $a In this book, leaders in the field explore our current understanding of thrombosis and hemostasis in cancer and address key questions on the subject. Among the topics discussed are the mechanisms that cancers use to activate the coagulation system, and those by means of which an activated coagulation system can lead to more aggressive cancer growth. Clinical chapters examine the role of thrombosis prophylaxis and treatment, central line-associated thrombosis, and cancer-associated hemorrhage. Subsequent chapters deal with the management of chemotherapy-induced thrombocytopenia, anticoagulation in the presence of brain metastases, and other unique challenges in the interaction of thrombosis and hemostasis in cancer. It has been 150 years since Armand Trousseau first described the well-known association between cancer and an increased risk of thrombosis, which may be considered the first paraneoplastic syndrome ever identified. More recently, numerous studies have indicated that activation of the coagulation system by cancer not only increases the likelihood of thrombosis, but is also associated with a more aggressive cancer phenotype. By familiarizing readers with the latest developments in this complex and challenging field, the book offers a valuable resource for scientists and clinicians alike.
650 0 $a Hemorrhagic diseases. $3 849773
650 0 $a Thrombosis. $3 308953
650 0 $a Hemostasis. $3 308954
650 0 $a Cancer $x Complications. $3 348677
650 1 4 $a Oncology. $3 195181
650 2 4 $a Hematology. $3 274899
650 2 4 $a Cancer Research. $3 273660
700 1 $a Soff, Gerald. $3 849772
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Cancer treatment and research ; $v v. 114. $3 452091
856 4 0 $u https://doi.org/10.1007/978-3-030-20315-3
950 $a Medicine (Springer-11650)